MedPath

Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple procedure (SPARROW): a multicenter, randomized controlled trial

Recruiting
Conditions
Pancreatic cancer
10017990
10019815
10014713
Registration Number
NL-OMON56173
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
344
Inclusion Criteria

• Patients undergoing elective pancreatoduodenectomy with a high risk for
contaminated bile defined as patients with preoperative biliary drainage or an
ampullary malignancy.
• Age of 18 years

Exclusion Criteria

• Pregnancy
• Contraindication for the study antibiotics (e.g. allergy or intolerance)
• Indication for endocarditis prophylaxis
• Preoperative planned therapeutic antibiotic treatment after surgery (i.e. for
cholangitis or liver abscesses)
• A reduced renal function, defined as an eGFR of <60 ml/min/1.73m2 measured on
the closest timepoint prior to pancreatoduodenectomy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath